Trastuzumab and paclitaxel in patients with EGFR mutated...

  • Main
  • 2018 / 7
  • Trastuzumab and paclitaxel in patients with EGFR mutated...
British Journal of Cancer 2018 / 7

Trastuzumab and paclitaxel in patients with EGFR mutated NSCLC that express HER2 after progression on EGFR TKI treatment

de Langen, Adrianus J., Jebbink, M., Hashemi, Sayed M. S., Kuiper, Justine L., de Bruin-Visser, J., Monkhorst, Kim, Thunnissen, Erik, Smit, Egbert F.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
British Journal of Cancer
DOI:
10.1038/s41416-018-0194-7
Date:
July, 2018
File:
PDF, 378 KB
english, 2018
Conversion to is in progress
Conversion to is failed